MENU
+Compare
SNGX
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$2.43
Change
-$0.01 (-0.41%)
Capitalization
6.1M

SNGX Soligenix Inc. Forecast, Technical & Fundamental Analysis

a manufacturer of biodefense vaccines and oral therapeutic products

Industry Biotechnology
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SNGX with price predictions
Feb 21, 2025

SNGX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SNGX turned positive on February 06, 2025. Looking at past instances where SNGX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SNGX's RSI Oscillator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where SNGX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 13, 2025. You may want to consider a long position or call options on SNGX as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNGX advanced for three days, in of 215 cases, the price rose further within the following month. The odds of a continued upward trend are .

SNGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.027) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). SNGX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.218).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SNGX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNGX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SNGX is expected to report earnings to rise 15.38% to -150 cents per share on May 12

Soligenix Inc. SNGX Stock Earnings Reports
Q1'23
Est.
$-1.50
Q4'22
Missed
by $0.17
Q3'22
Beat
by $0.02
Q2'22
Beat
by $0.02
Q1'22
Missed
by $0.03
The last earnings report on March 28 showed earnings per share of -129 cents, missing the estimate of -112 cents. With 15.51K shares outstanding, the current market capitalization sits at 6.10M.
A.I. Advisor
published General Information

General Information

a manufacturer of biodefense vaccines and oral therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPB79.220.10
+0.13%
Spectrum Brands Holdings
TPIC1.46-0.01
-0.34%
TPI Composites
FLGT16.46-0.17
-1.02%
Fulgent Genetics
IPG27.07-0.49
-1.78%
Interpublic Group of Companies (The)
RNAZ8.07-1.29
-13.82%
TransCode Therapeutics Inc

SNGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been loosely correlated with THAR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNGX jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
-0.41%
THAR - SNGX
46%
Loosely correlated
+1.99%
VRAX - SNGX
36%
Loosely correlated
+2.75%
QURE - SNGX
36%
Loosely correlated
-0.93%
ATHA - SNGX
31%
Poorly correlated
-3.21%
VNDA - SNGX
30%
Poorly correlated
-1.34%
More